ARTICLE | Company News
Cold Spring Harbor Laboratory, GlaxoSmithKline deal
April 20, 2015 7:00 AM UTC
The partners are discovering and developing small molecules to regulate the activity of protein tyrosine phosphatase 1B ( PTP-1B; PTPN1) to treat obesity and Type II diabetes. GSK and Cold Spring wi...